Qiwi (NASDAQ:QIWI) and Tabula Rasa HealthCare (NASDAQ:TRHC) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Institutional and Insider Ownership

29.0% of Qiwi shares are held by institutional investors. Comparatively, 75.2% of Tabula Rasa HealthCare shares are held by institutional investors. 14.0% of Tabula Rasa HealthCare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Qiwi and Tabula Rasa HealthCare’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Qiwi $363.00 million 1.50 $53.24 million $1.04 11.65
Tabula Rasa HealthCare $134.55 million 11.19 $14.29 million ($0.04) -1,859.50

Qiwi has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than Qiwi, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent recommendations and price targets for Qiwi and Tabula Rasa HealthCare, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Qiwi 1 0 1 0 2.00
Tabula Rasa HealthCare 0 2 10 0 2.83

Qiwi presently has a consensus target price of $18.00, suggesting a potential upside of 48.51%. Tabula Rasa HealthCare has a consensus target price of $71.55, suggesting a potential downside of 3.81%. Given Qiwi’s higher probable upside, research analysts plainly believe Qiwi is more favorable than Tabula Rasa HealthCare.


This table compares Qiwi and Tabula Rasa HealthCare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Qiwi 12.66% 15.13% 7.60%
Tabula Rasa HealthCare -16.78% 4.55% 2.37%

Risk and Volatility

Qiwi has a beta of 2.8, suggesting that its share price is 180% more volatile than the S&P 500. Comparatively, Tabula Rasa HealthCare has a beta of 2.85, suggesting that its share price is 185% more volatile than the S&P 500.


Qiwi beats Tabula Rasa HealthCare on 8 of the 14 factors compared between the two stocks.

Qiwi Company Profile

Qiwi Plc engages in the provision of payment services through physical, online, and mobile channels. It operates through the following segmentsL Payment Services, Consumer Financial Services, and Corporate and Other Category. The Payment Services segment involves in the virtual distribution services, including QIWI Wallet and applications, payment channels and methods; physical distribution, including kiosks, terminals, and retail points of service, contact money remittance system; and merchant focused services, such as QIWI Cashier or acquiring services. The Consumer Financial Services segment encompasses consumer lending business SOVEST. The Corporate and Other Category segment includes expenses associated with the corporate operations of QIWI Group as well as R&D, projects, and emerging business models. The company was founded on February 26, 2007 and is headquartered in Nicosia, Cyprus.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Receive News & Ratings for Qiwi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qiwi and related companies with MarketBeat.com's FREE daily email newsletter.